These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27459504)

  • 1. Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer.
    Kanda M; Tanaka C; Kobayashi D; Tanaka H; Shimizu D; Shibata M; Takami H; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Nakayama G; Fujiwara M; Kodera Y
    Int J Cancer; 2016 Nov; 139(10):2290-8. PubMed ID: 27459504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
    Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
    Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
    Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BARX2 expression is downregulated by CpG island hypermethylation and is associated with suppressed cell proliferation and invasion of gastric cancer cells.
    Ma J; Xia LL; Yao XQ; Zheng SM; Li S; Xu LS; Sha WH; Li ZS
    Oncol Rep; 2020 Jun; 43(6):1805-1818. PubMed ID: 32236603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
    Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
    Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
    Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
    Kanda M; Nomoto S; Oya H; Hashimoto R; Takami H; Shimizu D; Sonohara F; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Murotani K; Fujiwara M; Kodera Y
    J Exp Clin Cancer Res; 2014 Oct; 33(1):88. PubMed ID: 25330808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
    Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
    Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma.
    Matsumura S; Imoto I; Kozaki K; Matsui T; Muramatsu T; Furuta M; Tanaka S; Sakamoto M; Arii S; Inazawa J
    Clin Cancer Res; 2012 Jul; 18(13):3541-51. PubMed ID: 22573353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sushi domain containing two reflects the malignant potential of gastric cancer.
    Umeda S; Kanda M; Miwa T; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Cancer Med; 2018 Oct; 7(10):5194-5204. PubMed ID: 30259711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.
    Shimizu D; Kanda M; Tanaka H; Kobayashi D; Tanaka C; Hayashi M; Iwata N; Niwa Y; Takami H; Yamada S; Fujii T; Nakayama G; Fujiwara M; Kodera Y
    Sci Rep; 2017 Feb; 7():42089. PubMed ID: 28165032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer.
    Ling ZQ; Lv P; Lu XX; Yu JL; Han J; Ying LS; Zhu X; Zhu WY; Fang XH; Wang S; Wu YC
    PLoS One; 2013; 8(6):e67195. PubMed ID: 23826230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance.
    Zhu X; Liu J; Xu X; Zhang C; Dai D
    Int J Oncol; 2015 Jan; 46(1):195-204. PubMed ID: 25355626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.